BioCentury
ARTICLE | Company News

Cangen, Olympus Corp. deal

May 30, 2005 7:00 AM UTC

The companies will collaborate to develop a DNA- and protein-based diagnostic for lung cancer. Cangen will use Olympus' microarray technology for the DNA-based portion of the test. ...